NK cell triggering by the human costimulatory molecules CD80 and CD86.

Area of Science:

• Immunology
• Cell Biology
• Cancer Research

Background:

• NK cell effector functions rely on a balance of activating and inhibitory signals.
• While inhibitory receptors are well-studied, activating receptor-ligand interactions remain less understood.
• Murine NK cells are known to be triggered by CD80, CD86, and CD40.

Purpose of the Study:

• To investigate if human CD80 and CD86 can act as triggering molecules for human NK cells.
• To determine the susceptibility of tumor cells expressing human CD80/CD86 to NK cell-mediated lysis.
• To explore the involvement of CD28 and CTLA-4 in this triggering mechanism.

Main Methods:

• Utilized NK cell lines derived from peripheral blood mononuclear cells (PBMC).
• Engineered murine B16.F1 melanoma cells to express human CD80 or CD86.
• Employed blocking monoclonal antibodies (mAb) to assess the role of transfected molecules.
• Used flow cytometry and redirected lysis assays to investigate NK cell receptor expression.

Main Results:

• Human CD80 and CD86 expression on melanoma cells significantly increased their susceptibility to lysis by human NK cell lines.
• Blocking antibodies against CD80 and CD86 reduced NK cell-mediated cytotoxicity.
• NK cell triggering by CD80/CD86 was independent of CD28 and CTLA-4, as these were not detected on the NK cell lines.

Conclusions:

• Human CD80 and CD86 function as triggering molecules for human NK cell-mediated cytotoxicity.
• Tumor cells expressing CD80/CD86 become more vulnerable to NK cell attack.
• Human NK cells may utilize alternative receptors or variants for CD80/CD86 interaction, distinct from CD28/CTLA-4.